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Abstract 
Objective: The study aimed to develop a predictive model of how Type D personality 
influences health behaviors, social support, and symptom severity and assess its 
generalizability to a range of chronic illnesses. Design: Participants were classified as either 
healthy (n = 182) or having a chronic illness (n = 207). Participants completed an online 
survey measuring Type D and a range of health-related variables. Chronic illness participants 
were classified as having either a functional somatic syndrome (i.e. chronic fatigue syndrome 
or fibromyalgia), where the underlying pathological processes were unclear, or illnesses such 
as type 2 diabetes, osteoarthritis, or rheumatoid arthritis, where the causes are well 
understood. Main Outcome Measures: Outcome measures were health behaviors, social 
support, and both physical and psychological symptoms. Results: The rate of Type D was 
higher in chronic illness participants (53%) than in healthy controls (39%). Negative 
affectivity (NA) and social inhibition (SI) both correlated with outcome measures, although 
NA was generally the stronger predictor. Using NA and SI as independent subscales led to 
superior prediction of health outcomes than using categorical or continuous representations. 
Conclusion: Findings suggest that the relationship between Type D and health outcomes may 
generalize across different chronic illnesses. 
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1. Introduction 
Type D personality is defined as the presence of high levels of both negative 
affectivity and social inhibition. Negative affectivity represents the tendency to experience 
negative emotions, and social inhibition represents the tendency to withhold negative 
emotions for fear of rejection or judgment by others (Denollet, 2005). People with Type D 
personality are theorized to engage in more deleterious health-related behaviors and 
perceptions than those without Type D (Denollet & Pedersen, 2008; Williams et al., 2008), 
due largely to Type D representing a general susceptibility to psychological distress. Type D 
has been associated with a variety of negative health outcomes in cardiovascular disease 
(Pedersen & Schiffer, 2011) and chronic heart failure patients (Conraads et al., 2006), and 
more recently in conditions such as cancer (Mols, Denollet, Kaptein, Reemst, & Thong, 
2012) type 2 diabetes (Nefs et al., 2015), Parkinson’s disease (Dubayova et al., 2013), 
ulcerative colitis (Sajadinejad, Molavi, Asgari, Kalantari, & Adibi, 2012) and migraine (Chan 
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& Consedine, 2014). Although most Type D research has focused on cardiovascular disease 
and chronic heart failure patients, the generality of the mechanisms thought to underpin the 
relationship between Type D and poor health outcomes suggest that Type D could influence a 
broader range of chronic conditions.  
Despite extensive research on Type D personality, several gaps remain. First, 
although Type D research has focused on its role in particular diseases, we are not aware of 
research that has compared the relationship between Type D and health status in healthy 
controls with chronic illness groups, in order to examine whether Type D represents a 
generalized risk factor for negative health outcomes and symptom experiences. Second, a 
range of debates have emerged about how Type D should be represented and integrated into 
models of health outcomes. Specifically, these debates include (a) whether Type D is 
dimensional or dichotomous, (b) whether the two subscales of type D have interactive or only 
additive effects, (c) whether the two subscales are equally relevant to disease processes, and 
(d) whether the effect of Type D on general health outcomes differs between chronic illnesses 
(Ferguson et al., 2009; Horwood, Anglim, & Tooley, 2015). Thus, the purpose of the present 
study was develop and assess the generalizability of a model of Type D on health outcomes 
in both healthy controls and several high-prevalence, high-impact chronic conditions. As part 
of building such a model we aimed to contribute to the ongoing debates about the 
representation of Type D.  
1.1. Type D Personality  
Type D is typically diagnosed by scoring above a threshold on both negative 
affectivity and social inhibition subscales of the DS14, the standard measure of Type D 
personality (Denollet, 2005). These subscales share some overlap with the Big 5 traits of 
neuroticism and introversion respectively (Horwood et al., 2015).  Type D personality is 
present in healthy and clinical populations with some evidence suggesting greater prevalence 
in specific illnesses. Estimates of Type D prevalence in healthy populations have varied from 
13% (Mommersteeg, Kupper, & Denollet, 2010) to 24% (Pedersen & Denollet, 2004; Zohar, 
Denollet, Lev Ari, & Cloninger, 2011) to 38% (Horwood, Chamravi, & Tooley, 2014; 
Williams et al., 2008). In cardiovascular and cardiac samples the rate is around 21% to 31% 
(Mols & Denollet, 2010a), however in non-cardiac clinical samples estimates include 19% in 
cancer patients (Husson, Denollet, Oerlemans, & Mols, 2013), 29% in type 2 diabetes 
patients (Nefs et al., 2015), and 59% for female patients with ulcerative colitis  (Sajadinejad 
et al., 2012). This variation in prevalence may suggest that Type D personality is either a 
greater risk for, or consequence of, some illnesses than others.  
1.2. Type D Personality and Health Outcomes 
Type D personality is thought to influence health status via a number of interacting 
biopsychosocial mechanisms. Individuals with Type D personality experience a range of 
heightened negative emotions such as worry and fear, and possess a negative view of the 
world, others, and themselves (Denollet, 2005). Additionally, their increased social inhibition 
means that they are less likely to outwardly express their distress (Denollet et al., 2006) and 
more likely to engage in maladaptive coping strategies, such as resignation and withdrawal 
(Martin et al., 2011; Polman, Borkoles, & Nicholls, 2010). Type D individuals tend to report 
a greater range and number of symptoms, and perceive their condition as being more serious 
and prolonged than non-Type D patients (Jellesma, 2008). Nevertheless, they are less likely 
to engage in constructive health behaviors to maintain or improve their health status (Pelle, 
Schiffer, Smith, Widdershoven, & Denollet, 2010; Williams et al., 2008).  
Recent studies have reported evidence of HPA axis dysregulation in Type D patient 
groups, indicating a physiological dimension to the way in which the Type D profile may 
negatively affect health outcomes (Molloy, Perkins-Porras, Strike, & Steptoe, 2008; 
TYPE D AND CHRONIC ILLNESS 
 
 
3 
Whitehead, Perkins-Porras, Strike, Magid, & Steptoe, 2007). After adjusting for depression, 
Type D personality independently predicted increased cortisol levels in healthy individuals 
(Habra, 2003) and both increased cortisol (Whitehead et al., 2007) and oxidative stress 
(Kupper, Gidron, Winter, & Denollet, 2009) in cardiac patients. As such, it is likely that 
maladaptive psychological and behavioral responses to stress that are linked to the Type D 
profile are also associated with chronic physiological changes that are deleterious to the 
health of the individual by increasing susceptibility to disease and aging (Habra, 2003; 
Rosmond & Björntorp, 2000) . 
While Type D research has focused mainly on cardiovascular diseases, the possible 
mechanisms of action described above could have influential roles in other high-prevalence 
and high-impact chronic illnesses. Researchers examining the role of Type D in conditions 
such as type 2 diabetes (e.g. Nefs et al., 2015), metabolic syndrome (e.g. Mommersteeg et al., 
2010), and cancer (Mols et al., 2012) have found that Type D is associated with poorer 
mental and physical health status, and prolonged illness duration. Following a systematic 
review of Type D in the general population, Mols and Denollet (2010b) reported that Type D 
was associated with increased physical and mental health problems and disease promoting 
mechanisms in non-clinical, and even healthy populations. Michal et al. (2011) reported that 
Type D individuals were at severely increased risk for mental distress, major psychosocial 
stressors, and increased health care utilization. In a sample of over 3000 cancer survivors, 
Mols et al. (2012) found that Type D patients reported significantly higher levels of general 
somatic symptoms, sleep disturbance, pain, and fatigue.  Similarly, in a recent population 
survey of more than 5000 Swedish adolescents, Type D was associated with higher levels of 
self-reported psychosomatic symptoms, musculoskeletal pain, and sleep disturbance 
(Condén, Leppert, Ekselius, & Åslund, 2013; Condén, Rosenblad, Ekselius, & Aslund, 2014). 
Other somatic research has found that negative affectivity and social inhibition are also each 
independently associated with increased somatization and unexplained symptoms (Watson & 
Pennebaker, 1989; Wongpakaran & Wongpakaran, 2014). Because, even in healthy 
populations, Type D personality is associated with somatic complaints and exaggerated 
symptom reporting, we hypothesize that functional somatic syndromes, conditions that are 
characterized primarily by general somatic complaints of unclear etiology, such as chronic 
fatigue syndrome or fibromyalgia, may be more susceptible to the effects of Type D 
personality than illnesses of known etiology such as type 2 diabetes or arthritis.  
1.3. Representations of Type D in Models of Health Outcomes 
Type D has been conceptualized traditionally as a categorical construct resulting from 
the combined effects of high negative affectivity and high social inhibition (Denollet, 
Pedersen, Vrints, & Conraads, 2013; Denollet et al., 1996). This implies several questionable 
assumptions about the effect of Type D on health related outcomes. First, it assumes that 
negative affectivity and social inhibition have an interactive effect that is greater than the sum 
of the two main effects. Second, it implies that the main effects of negative affectivity and 
social inhibition are of similar importance in predicting health outcomes. Third, it suggests 
that there is a point of sharp discontinuity in the combined effect of social inhibition and 
negative affectivity on health outcomes, as opposed to a more linear effect that one would 
expect from a continuous variable.  
Assessing personality in a dichotomous fashion almost always discards meaningful 
variance and has the potential to misclassify people who fall close to either side of the split 
(Haslam, Holland, & Kuppens, 2012; Vollrath & Torgersen, 2002). The reduced prediction of 
dichotomous variables holds whether using a single dichotomous Type D variable or creating 
multiple groups based on combinations of dichotomous NA and SI  (e.g., Denollet et al., 
2013). Recently several researchers have suggested that conceptualizing Type D as a 
dimensional construct is more consistent with personality trait theory, and should lead to 
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greater predictive validity of health outcomes (e.g. see Bergvik, Sørlie, Wynn, & Sexton, 
2010; Ferguson et al., 2009; Horwood et al., 2015; Kelly-Hughes, Wetherell, & Smith, 2014; 
Romppel, Herrmann-Lingen, Vesper, & Grande, 2012). Researchers have examined measures 
of Type D both as the sum (Horwood et al., 2015) and the product (Stevenson & Williams, 
2014) of the two Type D subscales. However, there is limited research systematically 
comparing different representations of Type D in terms of predictive validity for health 
outcomes. This is a necessary step for conceptualization and practical utility of Type D in 
health research. 
1.4. The Current Study 
The present study aimed to develop models of how Type D personality influences 
health behaviors, social support, and symptom severity in chronic illness. We aimed to assess 
both the generalizability of models of Type D on health outcomes and refine understanding of 
how Type D personality should be represented in predictive models. To achieve these aims, 
we obtained a sample of healthy controls as well as individuals with a chronic illness that 
were categorized as having either a functional somatic syndrome (i.e., chronic fatigue 
syndrome or fibromyalgia) or an illness of clear etiological origins (i.e., type 2 diabetes, 
rheumatoid arthritis, or osteoarthritis). We examined predictive models of Type D on 
perceived social support, health behaviors, and physical and psychological symptoms. 
Specifically, we compared models using different representations of Type D and examined 
whether the effect of Type D varied between healthy and chronic illness groups and between 
functional somatic syndromes and illnesses of known etiology. 
Consistent with previous prevalence research, we expected that the rate of Type D 
personality would be higher in chronic illness participants compared to healthy controls. As 
one of the characteristics of Type D personality is the tendency to report more somatic 
symptoms (Mols & Denollet, 2010b), we also predicted that the rate of Type D would be 
higher in functional somatic syndrome’s compared to illnesses of known etiology. Based on 
recent findings by Kelly-Hughes, Wetherell and Smith (2014) and Stevenson and Williams 
(2014) we also predicted that negative affectivity and social inhibition would be superior in 
predicting health behaviors, social support, and symptom severity over categorical or 
continuous representations of Type D. Finally, we also predicted that Type D would 
differentially predict health behaviors, social support, and symptom severity between healthy 
controls and chronic illness sufferers, and between functional somatic syndromes and 
illnesses of known etiology.  
2. Method 
2.1. Participants and Procedure 
Participants were recruited via a number of illness support agencies (Diabetes 
Australia, CFS/ME Australia, FMS Support Australia) and social media sites (predominantly 
Facebook and Twitter). Participants completed an online survey composed of demographic 
questions, the DS14, the General Preventative Health Behaviors Checklist, the Social 
Network Support Scale and finally the Rotterdam Symptom Checklist. Participants were 
asked to respond yes or no to the follow statement regarding their health status: "Do you have 
a chronic illness that has been diagnosed by your GP or health care specialist? A chronic 
illness is defined as an illness that lasts at least six months in duration". Participants could 
select any of five chronic conditions; chronic fatigue syndrome, fibromyalgia, type 2 
diabetes, rheumatoid arthritis, and osteoarthritis, or enter free text for any condition that 
differed from, or was comorbid with, any of the five under investigation.  Ethics approval for 
this study was granted by our university Human Research Ethics Committee. 
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The final sample consisted of 389 participants after excluding participants with co-
morbid conditions (n = 60). This exclusion criteria was implemented to facilitate clear 
groupings, as well as exclude participants with conditions such as depression that may falsely 
inflate the negative affectivity or social inhibition scores of the DS14. Participants included 
208 chronic illness participants and 181 healthy controls. Chronic illness participants were 
classified as either (a) functional somatic syndrome (n = 100) if they had a diagnosis of 
chronic fatigue syndrome or fibromyalgia, or (b) illnesses of known etiology (n = 107) if they 
had a diagnosis of type 2 diabetes, rheumatoid arthritis, or osteoarthritis. The sample was 
aged between 18 and 77 years (M = 37.8, SD = 15.0) and 80.5% female. Most participants 
were born in Australia (76.6%) and 3.3% identified as Indigenous Australians. There was no 
significant differences between the healthy and chronic illness groups on age, gender, or 
ethnicity, however illnesses of known etiology participants were slightly older than those 
with a functional somatic syndrome, possibly due to the age-related degeneration associated 
with osteoarthritis.   
2.2. Materials 
Type D Personality Scale – DS14. The DS14 is a 14-item scale designed to measure 
the presence of Type D personality (Denollet, 2005). It uses a five-point response scale (0 = 
false, 1= rather false, 2 = neutral, 3 = rather true, 4 = true) and consists of two 7-item 
subscales: negative affectivity (NA) and social inhibition (SI). Using standard scoring, the 
DS14 provides subscale scores and a dichotomous diagnosis of Type D. Subscales are scored 
as the sum of item scores after item reversal. A diagnosis of Type D personality requires a 
score of 10 or more for both NA and SI subscales (Denollet, 2005). In a study of over 3000 
participants, Denollet (2005) found that both subscales were internally consistent (Cronbach's 
α of .88 and .86 respectively), stable over a 3-month period (test-retest r = .72 and .82). The 
present study found Cronbach’s α of .89 for NA and .87 for SI. Given arguments for 
conceptualizing Type D as a continuous construct (Ferguson et al., 2009; Kelly-Hughes et al., 
2014) we also computed a continuous Type D (product) variable (i.e., product of NA and SI) 
and a continuous Type D (sum) variable (i.e., the sum of NA and SI).  
Rotterdam Symptom Checklist. The Rotterdam Symptom Checklist (RSCL) (De 
Haes, 1990) is a 35-item scale used to measure the number of symptoms a person has 
experienced in the previous week. The measure uses a 4-item response scale where 1= not at 
all, 2 = a little, 3 = moderately, 4 = very much. The measure is comprised of two subscales, 
physical symptoms (e.g. chest pain, headaches) and psychological symptoms (e.g. depressed 
mood, anxious feelings). Scores for symptom severity are represented as the sum of items. 
Reliability and convergent validity for the RSCL is moderate to strong, 0.8 and 0.6 
respectively (Pelayo-Alvarez, Perez-Hoyos, & Agra-Varela, 2013). The present study found 
Cronbach’s α of .92 for psychological symptoms and .93 for physical symptoms.  
General Preventative Health Behavior Checklist. The General Preventive Health 
Behaviors (GPHB) checklist measures the degree to which an individual engages in 
preventative health-related behaviors and provides a global index of health behavior. The 
GPHB checklist asks participants to indicate to what degree they perform 29 different health-
related behaviors, answering on a 3-point scale (0 = do not do it, 1 = sometimes do it, 2 = yes 
always, or almost always do it). Examples of scale items include ‘Do not smoke’, ‘Limit 
alcohol intake’, and ‘Get a regular medical check-up’.   The present study obtained a 
Cronbach’s α statistic of .82.  
Social Network Support Scale. The Quality of Social Network and Social Support 
(SNSS) (Dalgard, Bjørk, & Tambs, 1995) questionnaire measures the overall quality of 
perceived social support. We used the shortened 9-item version, as used in Williams et al. 
(2008), that measures social support with friends and family but not neighbors. Response 
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scales varied across items but were either on a 0 to 3 or 0 to 2 scale. The measure showed 
good reliability in the current study (Cronbach’s α = .78). 
2.3. Data Analytic Approach 
We first compared the three groups on Type D prevalence (using categorical Type D), 
continuous Type D subscales, and health outcomes. We then examined the bivariate 
correlations between Type D subscales and outcome variables both for healthy and chronic 
illness participants. In order to contribute to the debate on how best to represent Type D, we 
compared the predictive validity (i.e., adjusted r-squared) of different representations of Type 
D predicting each health outcome. This involved comparing a range of categorical and 
continuous representations of Type D with and without interactions. The best predicting 
representation involved continuous SI and NA. There was also preliminary evidence for an SI 
by NA interaction. Thus, this representation was used in the subsequent regression models of 
Type D and chronic illness predicting health outcomes.  
3. Results 
3.1. Group Differences and Correlations 
Before engaging in regression modeling we examined differences in Type D and 
illness process variables between chronic illness and healthy control groups, as well as 
between participants with functional somatic syndromes and illnesses of known etiology (see 
Table 1). When Type D was treated as a categorical variable, chi-square tests indicated that 
the rate of Type D personality was significantly lower in healthy controls (39.0%) than in the 
illnesses of known etiology group (52.3%, p < .05)  and the functional somatic syndrome 
group (54.0%, p < .05), but there was no significant difference between the two chronic 
illness groups. Group means and standard deviations along with an overall ANOVA and post-
hoc tests for Type D subscales and illness process variables are also presented in Table 1.  In 
terms of Type D subscales, negative affectivity was higher in the illnesses of known etiology 
and functional somatic syndrome groups than in the healthy controls, while social inhibition 
was only higher in the functional somatic syndrome group compared to healthy controls.   
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Table 1.  
Descriptive Statistics and Significance Tests of Differences between Means for Healthy, 
Illnesses of Known Etiology, and Functional Somatic Syndrome groups. 
  Group    
Variable 
Healthy 
(A) 
Known 
Etiology  
(B) 
FSS 
(C)     
 (n = 182)  (n = 107) (n = 100) Overall Pairwise 
 % % % χ2 p χ2 
Type D Categorical 39.0 52.3 54.0 .02 A<B, A<C 
 
M (SD) M (SD) M (SD) 
ANOVA
p Tukey's HSD 
Negative Affectivity 10.77 (5.74) 12.57 (6.53) 13.18 (6.80) .004 A<B, A<C 
Social Inhibition 10.43 (5.97) 12.04 (6.23) 13.08 (6.09) .002 A<C 
Health Behaviors 32.29 (8.47) 35.90 (7.86) 34.32 (7.34) .001 A<B 
Social Support 10.70 (2.21) 9.87 (2.13) 9.87 (2.40) .002 A>B, A>C 
Physical Symptoms 37.28 (10.32) 45.32 (11.86) 58.78 (11.58) .000 A<B, A<C, B<C 
Psych Symptoms 17.45 (6.07) 18.70 (6.44) 23.45 (6.71) .000 A<C, B<C 
Note. FSS = Functional somatic syndrome. Tukey’s HSD and χ2 indicate significant group 
difference (p < .05).  
 
The correlations between Type D and health-related variables for the healthy controls 
and the chronic illness group are presented in Table 2. Several strong correlations were 
present between Type D and illness process variables. The pattern of correlations was similar 
for both healthy and chronic illness groups with the exception that the correlation between 
social inhibition and health behaviors was smaller in the chronic illness group. Correlations 
of Type D subscales with illness process variables were generally larger for negative 
affectivity than for social inhibition.  
Table 2.  
Correlation coefficients for healthy (upper diagonal) and chronic illness participants 
(lower diagonal) on all variables. 
 
 1 2 3 4 5 6 1. Negative Affectivity   .52 -.37 -.51 .40 .71 2. Social Inhibition  .54  -.32 -.53 .21 .37 3. Health Behaviors -.30 -.07  .29 -.18 -.37 
4. Social Support  -.50 -.42 .28  -.28 -.42 5. Physical Symptoms .35 .17 -.33 -.29  .67 
6. Psych Symptoms .74 .44 -.35 -.46 .65   
Note. Chronic illness group (n = 207) correlations are presented in lower diagonal; healthy 
control group correlations (n = 182) are presented in upper diagonal. Significant correlations 
(p < .05) are bolded. 
 
3.2. Models of Type D and Health Outcomes 
Linear regression was used to model the effect of Type D and illness group on health 
behaviors, social support, and symptom severity (physical and psychological). To facilitate 
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interpretation of regression coefficients, all numeric variables in the models were Z-score 
standardized. Chronic illness was coded 0 for healthy controls and 1 for chronic illness. The 
effect of having a functional somatic syndrome was coded 0 for healthy controls or illnesses 
of known etiology, and 1 for functional somatic syndrome. 
Before fitting regression models predicting health outcomes (i.e., health behaviors, 
social support, physical and psychological symptoms), we first performed a systematic 
comparison of the predictive validity of different representations of Type D. Specifically, for 
each health outcome we ran five regression models each with a different Type D 
representation: (1) dichotomous NA and SI main effects (i.e., based on cut-off scores of 
greater than or equal to 10); (2) dichotomous NA and SI main effects and interaction, which 
is also equivalent to including the four categories of low NA/SI, high NA only, high SI only, 
high NA/SI as per Denollet et al. (2013); (3) continuous NA and SI main effects; (4) 
continuous NA and SI main effects and interaction, (5) dichotomous Type D, (6) continuous 
Type D (Product), (7) continuous Type D (Sum). We obtained adjusted r-squared values for 
each regression (see Table 3). Results showed that dichotomous Type D was the weakest 
predictor (average adjusted r-squared = .126). Of the two continuous composite measures, the 
sum of NA and SI (average adjusted r-squared = .242) was better than the product (average 
adjusted r-squared = .213). However, reflecting the differential influence of NA and SI in 
predicting health outcomes, including continuous NA and SI as separate main effects 
provided superior prediction (average adjusted r-squared = .275). Adding the interaction in 
addition to continuous NA and SI main effects resulted in only slightly greater prediction 
(average adjusted r-squared = .279). Specifically, the NA by SI interaction only led to a 
significant r-squared change for health behavior.  Dichotomous NA and SI resulted in poorer 
prediction than continuous NA and SI, but the general pattern of the interaction providing 
minimal benefit over the main effects still held. We also performed the above regressions 
separately for healthy and chronic illness groups and the same relative ranking of regressions 
emerged. Given these results, continuous representations of NA, SI, and the NA by SI 
interaction were included in subsequent regression models. 
Table 3.  
Variance Explained in Health Behaviors, Social Support, and Symptom Severity from 
Alternative Type D Representations using Linear Regression 
 
Health 
Behavior 
Social 
Support 
Physical 
Symptoms 
Psych. 
Symptoms  
Predictors  
Adjusted 
 R² 
Adjusted 
R²  
Adjusted 
R² 
Adjusted 
R² 
Average 
Adjusted 
R2 
1. Dichotomous NA and SI Main 
effects  .059 .234 .088 .348 .182 
2. Dichotomous NA and SI Main 
effects and interaction .068 .233 .086 .347 .183 
3. Continuous NA and SI Main 
effects  .079 .332 .153 .538 .275 
4. Continuous NA and SI Main 
effects and interaction .092 .332 .154 .538 .279 
5. Dichotomous Type D .021 .195 .064 .223 .126 
6. Continuous Type D (Product)  .040 .318 .107 .386 .213 
7. Continuous Type D (Sum) .063 .333 .131 .443 .242 
Note. n = 389. Average adjusted R² values represent average variance explain for predictor 
set averaged over the four illness process outcome variables.  
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To examine whether the effect of Type D on health outcomes varied by clinical or 
functional somatic syndrome grouping variables, regression models predicting health 
behavior, social support, physical symptoms, and psychological symptoms were compared 
with and without interaction terms. Specifically, we included the six interactions created by 
crossing one of the Type D predictors (i.e., NA, SI, or the NA by SI interaction) with one of 
chronic illness indicator variables (i.e., chronic illness indicator or functional somatic 
syndrome indicator). Of the 24 interaction terms examined, two were statistically significant. 
First, the negative effect of negative affectivity on healthy behavior was reduced in the 
chronic illness group. Second, the negative effect of negative affectivity on social support 
was amplified in the functional somatic syndrome group. Thus, the hypothesis that Type D 
would have a differential effect by group was partially supported. As a result, subsequent 
regression predicting healthy behavior and social support retained group by Type D 
interactions. Because there no significant interactions in predicting symptom measures, 
interactions were excluded. 
Table 4. 	  	  
Regression Analysis of Type D predicting Health Behavior and Social Support	  	  
	  
 
Health Behavior Social Support 
 Model 1 Model 2 Model 1 Model 2 
Predictor  B SE B B SE B B SE B B SE B 
Intercept -.30* .07 -.32* .07 .21* .06 .19* .06 
Chronic Illness .52* .11 .54* .11 -.30* .10 -.30* .10 
FSS -.14 .13 -.17 .13 -.09 .11 -.05 .11 
Negative Affectivity -.32* .06 -.31* .09 -.34* .05 -.33* .08 
Social Inhibition -.03 .06 -.19* .08 -.28* .05 -.37* .07 
NA x SI .10* .04 .09* .04 -.04 .04 -.05 .04 
SI x Chronic Illness   .33* .14   .10 .12 
NA x Chronic Illness   -.07 .15   .19 .12 
SI x FSS   -.04 .16   .08 .13 
NA x FSS   .08 .15   -.37* .13 
         
Adjusted R² .14*  .15  .35*  .37*  
F (df) 13.55 (5, 381) 8.60 (9, 377) 44.22 (5, 382) 26.71 (9, 378) 
 
Note. Chronic illness was coded 0 = healthy, 1 = illnesses of known etiology or functional 
somatic syndrome. Functional somatic syndrome (FSS) was coded 0 = healthy or illnesses of 
known etiology, 1 = FSS. Negative affect (NA), social inhibition (SI), health behavior and 
social support were coded as z-scores. NA x SI was the product of NA and SI z-scores. 
* p<.05   
To examine the effect of Type D and group membership on health behavior and social 
support, we fit two regression models for each outcome variable where Model 1 included 
illness group indicators and Type D variables, and Model 2 added negative affectivity by 
group and social inhibition by group interactions. Coefficients and model fits are shown in 
Table 4. Chronic illness participants reported more positive health behaviors and less social 
support, but there was no effect of having a functional somatic syndrome compared to an 
illnesses of known etiology. With regards to Type D, the effect varied by outcome measure. 
Specifically, negative affectivity and social inhibition were equally predictive of social 
support, but negative affectivity was the more consistently important predictor of health 
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behavior. Also, in contrast to Type D theory, the sign of the interaction suggests that the 
combined effect of social inhibition and negative affectivity leads to an effect less than 
implied by the two main effects. Nonetheless, given the small size of the effect, and that this 
was the only significant NA by SI interaction across the four regressions, it is appropriate to 
treat the result with caution. Finally, there were the two significant group by Type D 
interactions discussed earlier.  
To examine the combined effect of Type D and the health-related mechanisms of 
social support and health behaviors on symptom reporting, we fit two regression models for 
both physical and psychological symptoms (see Table 5). Model 1 included illness group 
indicators and Type D variables and Model 2 added social support and health behaviors as 
predictors. For both physical and psychological symptoms, the functional somatic syndrome 
group reported many more symptoms, yet the effect of chronic illness was only significant 
for physical symptoms. With regards to Type D, negative affectivity but not social inhibition 
predicted greater levels of symptom reporting; this was particularly true for psychological 
symptoms. Adding health behaviors and social support to the model resulted in a small 
increase in variance explained with both variables predicting lower levels of both 
psychological and physical symptoms.  
Table 5. 
Regression Analysis for variables predicting Physical symptoms & Psychological 
Symptoms 
 
 Physical Symptoms Psychological Symptoms 
 Model 1 Model 2 Model 1 Model 2 
Predictor B SE B B SE B B SE B B SE B 
Intercept -.47* .06 -.48* .06 -.14* .05 -.15* .05 
Chronic Illness .49* .09 .51* .09 -.01 .08 .01 .08 
FSS .92* .10 .90* .10 .62* .09 .60* .09 
Negative Affectivity .33* .04 .26* .05 .69* .04 .63* .04 
Social Inhibition -.03 .04 -.07 .05 .02 .04 -.01 .04 
NAxSI -.05 .03 -.04 .03 -.03 .03 -.02 .03 
Social Support 
  
-.11* .05 
  
-.08* .04 
Health 
Behaviors 
 
-.10* .04  
 
-.10* .03 
         Adjusted R² .47* 
 
.49* 
 
.61* 
 
.62* 
 F (df) 70.16 (5,381) 53.48 (7,379) 120.03 (5,381) 90.72 (7,379) 
 
Note. Chronic illness was coded 0 = healthy, 1 = illnesses of known etiology or functional 
somatic syndrome. Functional somatic syndrome (FSS) was coded 0 = healthy or illnesses of 
known etiology, 1 = FSS. Negative affect (NA), social inhibition (SI), health behavior, social 
support, physical symptoms, and psychological symptoms were coded as z-scores. NA x SI 
was the product of NA and SI z-scores. 
* p<.05 
4. Discussion 
The present study aimed to extend the literature on Type D personality by 
investigating the presence and effect of Type D in a range of chronic illness groups. First, 
Type D prevalence was greater in chronic illness participants than in healthy controls, 
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however, contrary to our prediction, there was no significant difference in the rate of Type D 
between functional somatic syndromes and illnesses of known etiology. Second, models of 
the effect of Type D on health behaviors, social support, and symptom severity indicated that 
social inhibition and negative affectivity had differential effects with negative affectivity 
generally having the stronger impact, except in the case of social support where the effects 
were of a similar magnitude. Third, building on the previous point, including social support 
and negative affect as separate predictors led to much better prediction of health outcomes 
and symptom reporting than using only categorical Type D or any continuous sum or product 
composite of Type D. Fourth, while Type D predicted health behaviors, social support, and 
physical symptoms, the effect of Type D on symptoms appeared to be more direct, as 
opposed to operating through these potential mediators. Fifth, there were a small number of 
interactions between chronic illness group and Type D in predicting health behaviors, social 
support, and symptom severity. Overall, the results support the suggestion that Type D may 
be a significant factor in chronic illnesses beyond those associated with cardiac health.   
4.1. Type D Prevalence in Chronic Illness 
The prevalence of Type D was higher in the chronic illness group (53.6%) than in 
healthy controls (39.2%). The rate of Type D in the healthy controls was similar to other 
Australian population estimates (39.7%, Horwood et al., 2014) but higher than reported 
international estimates (24%, Mols & Denollet, 2010a). The rate in the chronic illness group 
was similar to hypertensive cardiac patients, who, in turn, had the highest rate of all cardiac 
patients (53%, Pedersen & Denollet, 2006). A similar pattern emerged when looking at Type 
D subscales with both social inhibition and negative affectivity being generally higher in 
chronic illness groups, although the data suggested that differences with healthy controls 
were greater for functional somatic syndromes than illnesses of known etiology. It may be 
that the continuous measures of Type D provided a more nuanced estimate of the differences 
between groups than is provided by categorical prevalence estimates. 
There are several possible explanations for the observed differences. First, it may be 
that merely having a chronic illness is sufficient to make people experience more negative 
emotions and reduce engagement in social interactions. Second, pre-morbid Type D 
individuals are likely to engage in fewer positive health behaviors than pre-morbid non-Type 
D’s; thus Type D may contribute to acquiring a chronic illness. Third, the trend in the data 
suggesting higher levels of negative affect and social inhibition in people with a functional 
somatic syndrome amplifies, or may reflect, the psychological mechanisms of the conditions. 
Finally, the differences also add weight to the proposal that Type D may have an indirect 
effect on symptoms via health behaviors and social support pathways. 
4.2. Type D and Health Outcomes 
Type D theory implies that a categorical representation is better than a continuous 
representation and that negative affectivity and social inhibition have a multiplicative effect. 
In response to the loss of prediction that occurs when converting a continuous variable into a 
dichotomous one, researchers have tried using both sums (Horwood et al., 2015) and products 
(Kelly-Hughes et al., 2014; Stevenson & Williams, 2014) of Type D subscales to create 
continuous scores for Type D. Consistent with more parsimonious principles of personality 
trait theory, results from the representational analysis challenge the categorical and 
multiplicative representations of Type D. Continuous Type D predicted better than 
categorical, the sum of negative affectivity and social inhibition predicted better than the 
product, and treating negative affectivity and social inhibition as separate predictors allowed 
for better prediction of health outcomes than either composite of negative affectivity and 
social inhibition. Furthermore, with the exception of health behaviors, the continuous forms 
of Type D did not provide incremental prediction, and even in the case of health behaviors, 
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the interaction effect was in the opposite direction to theory. These results are broadly 
consistent with findings from Stevenson and Williams (2014) and Kelly-Hughes et al (2014) 
showing that the interaction between negative affectivity and social inhibition rarely adds 
significant prediction over and above main effect. Rather, a better interpretation is that the 
two subscales are important predictors that operate as separate main effects. Importantly, 
negative affectivity appears to be a stronger predictor of health outcomes than social 
inhibition, although notable exceptions exist where the health related variable has a strong 
social component. Given the differential role of Type D predictors on health outcomes (e.g., 
social inhibition on social support), a Type D composite may hide these differential effects. 
Another broad question was whether Type D had a differential effect on health 
outcomes between healthy and chronic illness groups and between functional somatic 
syndromes and illnesses of known etiology. Given the overlap of mechanisms associated with 
both Type D and functional somatic syndrome such as poor health behaviors, low perception 
of social support, adoption of poor coping mechanisms and greater reporting of somatic 
complaints (Mols & Denollet, 2010b), we expected to find such interactions. While results 
indicated two significant interactions at the .05 level, we treat the results cautiously given that 
they were not significant at the Bonferroni adjusted .002 level. These two interactions 
showed that the effect of negative affect on social support was amplified in the functional 
somatic syndrome group and that the effect of social inhibition on health behaviors was 
reduced in the chronic illness group. Thus, on balance, there is more evidence that the 
relationship between Type D personality and health outcomes is similar across illnesses. This 
suggests that models of Type D personality may generalize across different illnesses.  
A theme explored in the results is the extent to which symptoms could be explained 
by Type D personality versus process variables such as health behaviors and social support. 
The theory of Type D suggests that Type D leads to a general inability to cope with stress and 
seek help, which can, in turn, lead to avoidance behaviors followed by health problems. In 
contrast, while Type D is associated with process variables that were related to symptoms, 
there was also support for a more direct role of negative affectivity. This was particularly 
evident when looking at the relationship between negative affectivity and psychological 
symptoms, where a very strong relationship was observed. This is broadly consistent with 
negative affectivity providing a general negative lens through which people experience both 
clinical and non-clinical health issues. It also made sense that this negative lens would be 
more relevant to psychological symptoms, which are arguably less constrained by the 
external world than physical symptoms. These results are also consistent with previous 
research that found Type D to be associated with higher rates of musculoskeletal pain and 
psychological symptom reporting (Condén et al., 2013). It may be that as the rate of negative 
affectivity and social inhibition increases, so does the subjective experience of illness and 
illness-related symptoms. Future research should examine whether the subjective experience 
of symptoms is consistent with objective measures of illness severity.  
Finally, prior research has presented evidence of a relationship between Type D, 
health behaviors, social support and symptom reporting (Svansdottir, van den Broek, 
Karlsson, Gudnason, & Denollet, 2012; Williams et al., 2008) in healthy and cardiac 
populations. The results of the present study offer some support to the proposed relationship, 
however it does appear that negative affectivity is the primary predictor in most cases. In 
predicting symptoms, health behavior and social support had incremental prediction, 
suggesting that there may be a cumulative effect of Type D with health behaviors and social 
support on reported symptom severity.  
4.3. Limitations and Future Research 
Several limitations in the present study are worth noting. First, the sample obtained 
had a large proportion of females. Females are more likely to report somatic symptoms than 
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males (APA, 2013), however Type D personality appears to occur relatively evenly between 
males and females (Mols et al., 2012). Second, the cross-sectional nature of the research 
means that causal relationships between Type D, illness, and health outcomes could not be 
answered. Third, the study had a limited ability to investigate Type D within specific illness 
groups. The data were collapsed across illnesses and across functional somatic syndrome 
status in order to ensure adequate power was achieved in the analyses. Further research could 
aim to develop a larger sample in order to look for more subtle effects of Type D and illness 
type. Finally, the data were obtained via self-report questionnaire, hence we are unable to 
ascertain the degree to which participant’s perceptions of social support or symptom severity 
are consistent with objective measures. 
4.4. Conclusion 
Overall, the current study contributes to a number of aspects of Type D research. 
While Type D may be a useful diagnostic heuristic for clinicians, predictive models clearly 
favor treating the subscales of Type D as continuous additive effects; the greater importance 
of negative affectivity and the absence of interaction effects between Type D subscales 
provides a further challenge to the novelty of the Type D construct. More broadly, the present 
study expanded Type D research to previously untested chronic illnesses, finding that models 
of Type D developed in CVD patients appear to be more generally applicable. These findings 
not only help to better understand the construct, but may assist in developing better models of 
personality and health outcomes for use in clinical and applied health-care settings. Specific 
reference to personality variables is often absent in health determinant models, however 
increasing evidence from Type D research suggests that particular traits, such as those 
captured by measures of Type D, represent important risk factors for health behaviors, illness 
perceptions and overall health status.  
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